Investor Relations

Press Releases

Date Title and Summary View
Toggle Summary NanoString Collaborates with MODEL-AD Consortium to Accelerate Alzheimer’s Disease Research
nCounter Mouse AD Gene Expression Panel Applied to Characterize Five Novel Mouse Models New nCounter Human AD Gene Expression Panel Launched at AAIC 2019 SEATTLE , July 15, 2019 (GLOBE NEWSWIRE) --   NanoString Technologies, Inc.  (NASDAQ:NSTG), a provider of life science tools for translational
View HTML
Toggle Summary NanoString to Release Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, July 31, 2019
SEATTLE , July 10, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release second quarter 2019 financial results after the close of trading on
View HTML
Toggle Summary Publication in the Journal for Clinical Cancer Research Uses NanoString’s GeoMx™ Digital Spatial Profiler to Discover Predictive Biomarkers for Immunotherapy
Researchers Used GeoMx Digital Spatial Profiler to Identify Biomarkers Predictive for Objective Response, Progression Free Survival and Overall Survival for Melanoma Patients Receiving Immunotherapy SEATTLE , June 18, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc.
View HTML
Toggle Summary NanoString Partners with Multiple Leading Contract Research Organizations to Provide Standardized PanCancer IO 360 Data Analysis Reports
Program Extends Ability of CAP CLIA Labs to Develop a Tumor Inflammation Signature Assay to Support Translational Research by Biopharmaceutical Companies SEATTLE , May 30, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for
View HTML
Toggle Summary NanoString to Present at the UBS Global Healthcare Conference
SEATTLE , May 15, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the UBS Global Healthcare
View HTML
Toggle Summary NanoString Technologies Releases Operating Results for First Quarter of 2019
SEATTLE , May 09, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the first quarter of 2019. First Quarter Financial Highlights Total product and
View HTML
Toggle Summary NanoString to Release First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9, 2019
SEATTLE , April 08, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release first quarter 2019 financial results after the close of trading on
View HTML
Toggle Summary NanoString and Leica Biosystems to Co-Market GeoMx Digital Spatial Profiling and Leica’s BOND RX Platforms for High Throughput Spatial Analysis
Combined Workflow Provides Complete Solution for Rapid, Automated, and Highly Multiplexed Profiling of Protein and RNA Biomarkers in FFPE Samples SEATTLE and NEWCASTLE UPON TYNE, UK , April 02, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools
View HTML
Toggle Summary NanoString and Abcam Enter Commercial Partnership to Provide Expanded Menu of Antibodies for GeoMx Digital Spatial Profiler
— Abcam to Develop Conjugated FFPE IHC Validated Antibodies Compatible with the GeoMx DSP — SEATTLE and CAMBRIDGE, UK , April 01, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products,
View HTML
Toggle Summary Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling
Integrated Workflow Combines NanoString’s GeoMx DSP High-Plex RNA Assays and Bio-Techne’s Highly Sensitive RNAscope Imaging Reagent Portfolio SEATTLE and MINNEAPOLIS , March 28, 2019 (GLOBE NEWSWIRE) -- Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and
View HTML